Ipsen is a France-based biopharmaceutical company that develops and commercializes generic medicines for the treatment of cancer and neurogenerative disease.
Business Model:
Revenue: $2.9B
Employees: 5,001-10,000
Address: 65 Quai Georges Gorse
City: Boulogne-Billancourt
State: other
Zip: 92100
Country: FR
Ipsen is a France-based biopharmaceutical company that develops and commercializes generic medicines for the treatment of cancer and neurogenerative disease.
Contact Phone:
Contact Email:
Listed Exchange:
PA
IPO Date:
8/22/2017
IPO Valuation:
$457M
Ticker Symbol:
IPN
IPO Price:
$15/share
Amount Raised:
$147M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|